Figure 1. Phenotypic and functional properties of MoDCs from healthy donors (HD) and myeloma patients (MM). Representative histograms showing the expression of CD1a, CD40, CD80, and HLA-DR on (A) immature and (B) mature MoDCs generated from a healthy donor and a myeloma patient. Numbers inside the histograms represent the mean fluorescence intensity (MFI). (C) Pooled data depicting the expression (MFI) of CD1a, CD40, CD80, and HLA-DR on mature MoDCs from all tested healthy donors (n = 10) and myeloma patients (n = 12). Bars indicate the mean MFI. (D) Allostimulatory capacity of mature MoDCs in activating alloreactive T cells in an MLR assay. Shown are the mean ± SD of the results obtained with cells from 7 healthy donors and 7 myeloma patients. (E) Antigen-presentation capacity of MoDCs to autologous T cells. Shown are the mean ± SD of the results of cells presenting recalled antigen PPD to autologous T cells obtained from 5 healthy donors and 5 myeloma patients. In these experiments, different T cell/DC ratios (10:1, 100:1, and 1000:1; noted in the figure) were used. * P values less than .05.
Figure 1.

Phenotypic and functional properties of MoDCs from healthy donors (HD) and myeloma patients (MM). Representative histograms showing the expression of CD1a, CD40, CD80, and HLA-DR on (A) immature and (B) mature MoDCs generated from a healthy donor and a myeloma patient. Numbers inside the histograms represent the mean fluorescence intensity (MFI). (C) Pooled data depicting the expression (MFI) of CD1a, CD40, CD80, and HLA-DR on mature MoDCs from all tested healthy donors (n = 10) and myeloma patients (n = 12). Bars indicate the mean MFI. (D) Allostimulatory capacity of mature MoDCs in activating alloreactive T cells in an MLR assay. Shown are the mean ± SD of the results obtained with cells from 7 healthy donors and 7 myeloma patients. (E) Antigen-presentation capacity of MoDCs to autologous T cells. Shown are the mean ± SD of the results of cells presenting recalled antigen PPD to autologous T cells obtained from 5 healthy donors and 5 myeloma patients. In these experiments, different T cell/DC ratios (10:1, 100:1, and 1000:1; noted in the figure) were used. * P values less than .05.

or Create an Account

Close Modal
Close Modal